BioSenic receives EUR 1 million from Pregene in accordance with terminated license agreement and expect new negotiations on common revisited grounds Read more about BioSenic receives EUR 1 million from Pregene in accordance with terminated license agreement and expect new negotiations on common revisited grounds
Vivoryon Therapeutics N.V. to Present at Upcoming Conferences Read more about Vivoryon Therapeutics N.V. to Present at Upcoming Conferences
Operational EBIT of DKK 376 Million for the Fourth Quarter of 2022 Read more about Operational EBIT of DKK 376 Million for the Fourth Quarter of 2022
Clean Seas H1 FY23 Results – Investor Presentation Read more about Clean Seas H1 FY23 Results – Investor Presentation
Clean Seas H1 FY23 Results – Media Release Read more about Clean Seas H1 FY23 Results – Media Release